Prosthetic (Prosthesis) devices, such as an artificial leg, that replace a part of the body. Prostheses are typically used to replace parts lost by injury (traumatic) or missing from birth (congenital) or to supplement defective body parts. Inside the body, artificial heart valves are in common use with artificial hearts and lungs seeing less common use but under active technology development. Other medical devices and aids that can be considered prosthetics include artificial eyes, palatal obturator, gastric bands, and dentures.
DENTSPLY International Inc. announced that it has entered into a strategic partnership with DIO Corporation, based in Busan, South Korea. DIO operations include a state-of-the art manufacturing facility in Busan, producing dental implant devices and associated accessories, which are marketed in numerous countries including many emerging markets.
Members of IEEE, the world's largest technical professional association, are advancing the application of engineering sciences and technology with medicine and biology to make healthcare personal again.
Last year 12 700 knee replacement operations were carried out in Sweden. Most such operations go well, but some patients are affected by bacterial infection in the joint and have to be re-operated. This is a complicated procedure that does not always produce successful results, as shown in a thesis by Anna Stefánsdóttir from Lund University in Sweden.
The long-term performance of medical implant devices, like heart valves and cardiac stents, could be enhanced substantially by new bio-coating technology recently licensed to University of Alabama at Birmingham spin-out company Endomimetics LLC through the UAB Research Foundation.
Ziosoft, Inc., a leader in functional visualization and analytics, will launch its PhyZiodynamic solutions at the Radiology Society of North America (RSNA) being held November 28 – December 3, 2010 in Chicago. PhyZiodynamic solutions represent a generational leap in advanced visualization.
Sigma-Aldrich today announced a distribution agreement with Nanosys, Inc., an advanced materials architect. Under the agreement, Sigma-Aldrich, through its Aldrich Materials Science business, is now distributing Nanosys-created silicon nanowires to the global scientific research community for the development of new applications in technologies such as solid-state lighting, electronics and energy storage.
It may look the same, but it doesn't chew the same. Different dental treatment options for bilateral cleft lip and palate may result in similar aesthetic appearance, but they produce definite differences in jaw function. People with clefts of the lip and palate often have dental anomalies as well. The number, shape, and position of teeth can be affected. In particular, the permanent lateral incisor is frequently absent or misshapen.
Using beams of light to allow amputees not only to control but also to feel the movement of prosthetic limbs is the ambitious goal of a new $5.6 million Department of Defense initiative.
VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices, today announced the Implantable Miniature Telescope (by Dr. Isaac Lipshitz), designed to improve vision in patients with end-stage age-related macular degeneration (AMD) is named "Best of What's New" 2010 by Popular Science magazine.
Two experimental brain-machine technologies - deep brain stimulation coupled with physical therapy and a thought-controlled computer system-may offer new therapies for people with stroke and brain injuries, new human research shows. In addition, an animal study shows a new artificial retina may restore vision better than existing prosthetics. The findings were announced today at Neuroscience 2010, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health.
Herbal and dietary supplements are popular. People claim they make their joints feel better, their bones stronger, and their hearts healthier. But a recent study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City shows that many of these people may not realize their favorite supplement, mixed with prescription medications, may be putting their lives in danger, especially if they are taking warfarin - a blood-thinning medication commonly prescribed to patients living with atrial fibrillation to lower their risk of stroke.
The Health Minister of Spain Leire Pajin revealed that doctors there are looking for a suitable match from a dead donor to carry out the world’s first leg transplant. The announcement was made at an international conference on organ transplants in Madrid.
Instead of getting hung up on labels adopted in the heat of political battle, they should focus instead on Supreme Court precedents that found that taxes designed to influence behavior, like taxes to deter the sale of particularly dangerous firearms, were constitutional, provided they raised revenue in the process.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that it has begun European distribution of PerClot®, a novel polysaccharide hemostatic agent used to control bleeding during surgical procedures or following traumatic injuries.
A significant majority of dental implant patients are older with facial aging and their dentists may need to consider the benefits of rejuvenation techniques, such as Botox, for maximizing the cosmetic outcomes of the procedure, according to a leading cosmetic surgeon speaking at the American Academy of Implant Dentistry annual meeting.
PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has announced plans for a Phase 2 clinical trial of PMX-60056 in interventional cardiology, and the establishment of a focused Heptagonist Clinical Advisory Board (CAB). PMX-60056 is a synthetic small-molecule designed to reverse the anticoagulant activity of heparin and low molecular weight heparins (LMWH).
HOYA ConBio™, a global leader in dental and aesthetic lasers, today announced an extension of its sponsorship agreement with the Las Vegas Institute for Advanced Dental Studies (LVI), the pioneer in live-patient, post-graduate dental training. The agreement ensures that VersaWave™ and DioDent™ Micro 980 lasers will continue to be featured at LVI's advanced teaching facilities through 2013.
A total of 15 world renowned cognitive scientists have been invited to share recent advances in their respective fields at the 6th Decade of the Mind Conference to be held at Fusionopolis from 18 - 20 October 2010. Jointly organised by A*STAR's Institute of High Performance Computing (IHPC), MINDEF's Defence Research & Technology Office (DRTech) and NUS's Temasek Laboratories, it is the first such conference in Asia to promote awareness of Cognitive Science research done in Asia and from around the world.
Danny Bluestein, Ph.D., Professor of Biomedical Engineering at Stony Brook University, has been awarded a five-year, $7.5 million grant by the National Institutes of Health. The award marks the first time a Stony Brook professor has received a Phase II Quantum Grant, given by The National Institute of Biomedical Imaging and Bioengineering (NIBIB), a division of the NIH, to make a profound improvement or quantum leap forward—in health care.
Covidien, a leading global provider of healthcare products, announced that its hernia and abdominal wall repair products were featured in 18 podium presentations at the 32nd International Congress of the European Hernia Society (EHS).
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.